Form 8-K - Current report:
SEC Accession No. 0001213900-26-050211
Filing Date
2026-04-30
Accepted
2026-04-30 16:06:12
Documents
48
Period of Report
2026-04-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0288588-8k_ostherapies.htm   iXBRL 8-K 32087
2 PRESS RELEASE ISSUED BY OS THERAPIES INCORPORATED ON APRIL 30, 2026 ea028858801ex99-1.htm EX-99.1 34729
3 SLIDE PRESENTATION DATED APRIL 30, 2026 ea028858801ex99-2.htm EX-99.2 36981
4 GRAPHIC ea028858801_ex99-2img1.jpg GRAPHIC 1230364
5 GRAPHIC ea028858801_ex99-2img2.jpg GRAPHIC 672229
6 GRAPHIC ea028858801_ex99-2img3.jpg GRAPHIC 266010
7 GRAPHIC ea028858801_ex99-2img4.jpg GRAPHIC 265107
8 GRAPHIC ea028858801_ex99-2img5.jpg GRAPHIC 266151
9 GRAPHIC ea028858801_ex99-2img6.jpg GRAPHIC 265412
10 GRAPHIC ea028858801_ex99-2img7.jpg GRAPHIC 369671
11 GRAPHIC ea028858801_ex99-2img8.jpg GRAPHIC 238955
12 GRAPHIC ea028858801_ex99-2img9.jpg GRAPHIC 226866
13 GRAPHIC ea028858801_ex99-2img10.jpg GRAPHIC 216698
14 GRAPHIC ea028858801_ex99-2img11.jpg GRAPHIC 424236
15 GRAPHIC ea028858801_ex99-2img12.jpg GRAPHIC 756568
16 GRAPHIC ea028858801_ex99-2img13.jpg GRAPHIC 858461
17 GRAPHIC ea028858801_ex99-2img14.jpg GRAPHIC 490046
18 GRAPHIC ea028858801_ex99-2img15.jpg GRAPHIC 573828
19 GRAPHIC ea028858801_ex99-2img16.jpg GRAPHIC 195600
20 GRAPHIC ea028858801_ex99-2img17.jpg GRAPHIC 519774
21 GRAPHIC ea028858801_ex99-2img18.jpg GRAPHIC 374057
22 GRAPHIC ea028858801_ex99-2img19.jpg GRAPHIC 405456
23 GRAPHIC ea028858801_ex99-2img20.jpg GRAPHIC 288751
24 GRAPHIC ea028858801_ex99-2img21.jpg GRAPHIC 318445
25 GRAPHIC ea028858801_ex99-2img22.jpg GRAPHIC 402924
26 GRAPHIC ea028858801_ex99-2img23.jpg GRAPHIC 292184
27 GRAPHIC ea028858801_ex99-2img24.jpg GRAPHIC 700618
28 GRAPHIC ea028858801_ex99-2img25.jpg GRAPHIC 345167
29 GRAPHIC ea028858801_ex99-2img26.jpg GRAPHIC 355022
30 GRAPHIC ea028858801_ex99-2img27.jpg GRAPHIC 220924
31 GRAPHIC ea028858801_ex99-2img28.jpg GRAPHIC 444115
32 GRAPHIC ea028858801_ex99-2img29.jpg GRAPHIC 387959
33 GRAPHIC ea028858801_ex99-2img30.jpg GRAPHIC 228323
34 GRAPHIC ea028858801_ex99-2img31.jpg GRAPHIC 398970
35 GRAPHIC ea028858801_ex99-2img32.jpg GRAPHIC 269589
36 GRAPHIC ea028858801_ex99-2img33.jpg GRAPHIC 269070
37 GRAPHIC ea028858801_ex99-2img34.jpg GRAPHIC 264637
38 GRAPHIC ea028858801_ex99-2img35.jpg GRAPHIC 98311
  Complete submission text file 0001213900-26-050211.txt   18679755

Data Files

Seq Description Document Type Size
39 XBRL SCHEMA FILE ostx-20260430.xsd EX-101.SCH 3023
40 XBRL LABEL FILE ostx-20260430_lab.xml EX-101.LAB 34239
41 XBRL PRESENTATION FILE ostx-20260430_pre.xml EX-101.PRE 22364
51 EXTRACTED XBRL INSTANCE DOCUMENT ea0288588-8k_ostherapies_htm.xml XML 3339
Mailing Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850
Business Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850 410-297-7793
OS Therapies Inc (Filer) CIK: 0001795091 (see all company filings)

EIN.: 825118368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42195 | Film No.: 26925090
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)